Peers for comparison


Market capitalization
‪79.47 B‬ KRWMicro cap
‪526.19 M‬ KRW
‪24.50 B‬ KRW
‪17.08 M‬
Beta (1Y)
0.16
Next report date
Report period
EPS estimate
Revenue estimate
Employees (FY)
114
Change (1Y)
+10+9.62%
Revenue / Employee (1Y)
‪214.96 M‬ KRW
Net income / Employee (1Y)
‪4.62 M‬ KRW

Company info


CEO
Geun-Yong Lee
Website
Headquarters
Cheongju-si
Founded
2003
IPO date
Aug 14, 2018
ISIN
KR7302550009
FIGI
BBG00LNLYGM4
Identifiers
ISIN KR7302550009
REMED Co., Ltd. engages in the development and manufacture of medical devices related to electronic medication. The firm focuses on brain rehabilitation business that utilizes Transcranial Magnetic Stimulation for the purpose of non-invasive treatment and rehabilitation of brain diseases. It operates through the following business divisions: Brain Rehabilitation, Chronic Pain Treatment, Aesthetics, and Others. The company was founded on July 31, 2003 and is headquartered in Cheongju-si, South Korea.
Performance
Revenue to profit conversion
Debt level and coverage
EPS
Next:—
Summarizing what the indicators are suggesting.
Oscillators
Neutral
Oscillators
Neutral
Summary
Neutral
Summary
Neutral
Summary
Neutral
Moving Averages
Neutral
Moving Averages
Neutral
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently asked questions


Today, 302550 trades at 2,590 KRW.

For broader market analysis, dive into the technicals on the REMED Co., Ltd. stock price chart.
REMED Co., Ltd. is scheduled to release its next earnings report on Mar 23, 2027.

Why it matters:
– Key event: Earnings often drive significant price moves
– Market expectations: Traders watch revenue, EPS, and guidance vs forecasts
– Volatility spike: Price swings can increase before and after the release

How to use it:
– Track upcoming reports in the Earnings Calendar
– Compare actual results with analyst estimates
– Monitor price reaction and volume on Supercharts
302550 stock is 3.73% volatile and has beta coefficient of 0.16.

What it means:
– Volatility: Shows how much the price fluctuates over time
– Beta > 1: More volatile than the market
– Beta < 1: Less volatile, more stable

Important to know:
– Volatility can increase during earnings, news events, or market stress
– Large-cap stocks like 302550 are typically less volatile than smaller companies

Track every detail on REMED Co., Ltd. stock chart and check out the list of the most volatile stocks — is REMED Co., Ltd. there?
To understand the 302550 stock performance, it's worth checking price changes for various periods to get the full picture:
– 1 day — −0.38%
– 1 week — +10.34%
– 1 month — +23.93%

302550 all-time low was 2,030 KRW (Oct 13, 2022), and its highest price is 7,910 KRW (Jun 11, 2020). Find more dynamics in the Stock Heatmap and on the REMED Co., Ltd. stock chart.
REMED Co., Ltd. market capitalization is ‪76.16 B‬, representing the total value of all its outstanding shares (price × shares outstanding).

What it means:
– Market cap is one of the key ways to classify companies (large-cap, mid-cap, etc.)
– It reflects how investors value the company today
– It changes constantly with stock price movements

What to look at next:
– Market cap trends: Rising cap may signal growth and investor confidence; falling cap can reflect risk or downturns
– Price vs shares: Changes can come from REMED Co., Ltd. stock price moves or share count (buybacks, issuance)
– Valuation ratios: Compare market cap with revenue and earnings
– Peer comparison: See how REMED Co., Ltd. stacks up against other companies
The safest way to buy REMED Co., Ltd. stocks is through a reliable broker. Create an account, fund it, and place a buy order.

You can trade 302550 directly from TradingView:
– Choose a broker: Explore our supported trading partners and pick one that fits your needs
– Compare options: View available brokers side by side to evaluate fees and features
– Connect your account: Open Supercharts, click “Trade”, select your broker, and log in
– Start trading: Place orders without leaving the chart

Tip: If you’re new to trading, try paper trading first — it lets you practice strategies in real market conditions without risking funds.
As of Nov 17, 2026, the company has 114 employees.

Why traders follow this data:
– Company scale: Employee count reflects the size and global reach of the business
– Operational footprint: Higher headcount often indicates broader product lines, retail presence, or services
– Trend signal: Changes over time can reflect hiring growth, restructuring, or efficiency improvements

See our rating of the largest employers to find more opportunities.
Investing in REMED Co., Ltd. depends on your goals, risk tolerance, and market conditions. It’s essential to analyze the stock before making a decision.

First, study REMED Co., Ltd. financials and track their dynamics on the Fundamental Graphs:
– Business fundamentals: Revenue, earnings, and growth trends
– Valuation: P/E ratio, market cap, and how it compares to peers
– Profitability: Margins, return on equity, and cash flow
– Dividends (if any): Yield, payout ratio, and consistency

Then explore our 302550 technicals – signals based on essential indicators calculations:
– Today — buy
– 1-week — sell
– 1-month — sell

Combine fundamental and technical analysis for better results.
REMED Co., Ltd. stock ticker depends on the exchange where it’s listed. On the KRX, its primary exchange, REMED Co., Ltd. stocks trade under the symbol 302550.

About tickers:
– Unique identifiers: A ticker is a short code used to find and trade a stock
– Exchange-specific: The same company may have different tickers across exchanges
– Search shortcut: Used on trading platforms, charts, and screeners

Remember:
– Some companies have multiple listings
– Always check the exchange prefix to avoid confusion

Learn how to find your desired assets in our Symbol Search.
Yes, you can track REMED Co., Ltd. financials in yearly and quarterly reports right on TradingView.

Use our Earnings Calendar to never miss important releases and spot opportunities early.
302550 net income for the last quarter is ‪700.92 M‬ KRW, while the quarter before that showed ‪1.12 B‬ KRW of net income which accounts for −37.15% change.

How to read this data:
– Track changes: Compare net income across quarters to spot trends
– Watch expectations: Compare with estimates to gauge performance
– Check margins: Net income reflects profitability after all expenses
– Look beyond one quarter: Consistency matters more than a single result

Follow other essential metrics in REMED Co., Ltd. financials:
– Revenue: Overall business growth
– Earnings per share: Rising EPS over time often points to improving business performance
– Margins (gross, operating): Efficiency and cost control
No, REMED Co., Ltd. does not currently pay dividends to its shareholders.

Instead of distributing profits as cash payments, the company may choose to reinvest earnings back into the business — for example, in growth, innovation, acquisitions, or debt reduction.

What to consider instead:
– Earnings growth: Is the company increasing profitability over time?
– Revenue expansion: Is the business scaling its operations?
– Free cash flow: Does it generate enough cash to potentially support future dividends?
– Share buybacks: Some companies return capital through repurchasing shares instead of dividends
302550 reached its all-time high of 7,910 KRW on Jun 11, 2020. Its all-time low was 2,030 KRW and was reached on Oct 13, 2022.

Explore the REMED Co., Ltd. stock price chart to see more price history, and discover companies reaching new all-time highs and lows.
REMED Co., Ltd. EBITDA is ‪3.39 B‬ KRW, with an EBITDA margin of 8.74%.

EBITDA is a measure of core operating performance, showing how much profit the company generates from its main business activities before accounting for financing and accounting-related costs.

What it means:
– Operating strength: Helps assess profitability from core operations
– Efficiency signal: Rising EBITDA often reflects improving business performance
– Comparability: Useful for comparing companies with different capital structures

What to look at next in REMED Co., Ltd. statements:
– Revenue growth: Shows whether the business is expanding
– Net income: Captures full profitability after all expenses
– Free cash flow: Shows actual cash generated
– Debt levels: Important when evaluating earnings quality